HSP90B1 and neoplasm: In terms of antigen-specific immunity, tumor-derived gp96-peptide complexes or cell-based gp96–Ig-secreting vaccines elicited specific T cell immunity against parent tumors in both rodent models and clinical trials [10, 11].